Sanofi Consumer Healthcare India Share Price
4204.00-1.40 (-0.03%)
-17.91% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 21% |
| - | - | - | 33% |
| - | - | - | -18% |
| 81% | 81% | 81% | 73% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
LUPIN
MANKIND
DRREDDY
AUROPHARMA
SANOFICONR
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,901.1 | ₹456833 Cr | 37.77 | 12.07 | 62.82 | ₹11479 Cr |
| 9,180.5 | ₹245426 Cr | 83.91 | 34.04 | 128.41 | ₹2568 Cr |
| 4,859.5 | ₹187320 Cr | 85.89 | 16.72 | 97.06 | ₹2163 Cr |
| 1,131.5 | ₹113217 Cr | 25.09 | 9.42 | 62.53 | ₹5040 Cr |
| 1,380.7 | ₹112212 Cr | 33.29 | 9.77 | 57.87 | ₹3879 Cr |
| 1,852.3 | ₹101155 Cr | 92.52 | 6.8 | 29.25 | ₹889 Cr |
| 2,123.2 | ₹97626 Cr | 17.66 | 30.95 | 154.36 | ₹5333 Cr |
| 2,336.5 | ₹96859 Cr | 47.42 | 13.75 | 71.08 | ₹1913 Cr |
| 1,162.5 | ₹96406 Cr | 29.92 | 5.32 | 63.99 | ₹4196 Cr |
| 1,657.8 | ₹93614 Cr | 25.22 | 17.95 | 96.84 | ₹3505 Cr |
| 4,204 | ₹9705 Cr | 36.49 | 29.91 | 121.23 | ₹240 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹236 Cr | ₹229 Cr | ₹251 Cr | ₹234 Cr | ₹221 Cr | ₹173 Cr | ₹171 Cr | ₹160 Cr | ₹172 Cr | ₹222 Cr | ₹225 Cr | ₹210 Cr | ₹100 Cr |
| ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹3 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹80 L | ₹3 Cr | ₹3 Cr | ₹1 Cr | ₹20 L |
| ₹242 Cr | ₹235 Cr | ₹256 Cr | ₹237 Cr | ₹227 Cr | ₹178 Cr | ₹176 Cr | ₹164 Cr | ₹173 Cr | ₹225 Cr | ₹227 Cr | ₹212 Cr | ₹101 Cr |
| ₹150 Cr | ₹144 Cr | ₹165 Cr | ₹152 Cr | ₹154 Cr | ₹111 Cr | ₹110 Cr | ₹98 Cr | ₹110 Cr | ₹141 Cr | ₹136 Cr | ₹116 Cr | ₹66 Cr |
| ₹96 Cr | ₹94 Cr | ₹94 Cr | ₹88 Cr | ₹76 Cr | ₹69 Cr | ₹67 Cr | ₹67 Cr | ₹64 Cr | ₹85 Cr | ₹92 Cr | ₹96 Cr | ₹35 Cr |
| ₹40 L | ₹50 L | ₹50 L | ₹60 L | ₹50 L | ₹40 L | ₹40 L | ₹3 Cr | ₹10 L | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹92 Cr | ₹91 Cr | ₹91 Cr | ₹84 Cr | ₹79 Cr | ₹67 Cr | ₹63 Cr | ₹61 Cr | ₹39 Cr | ₹84 Cr | ₹90 Cr | ₹95 Cr | ₹35 Cr |
| ₹69 Cr | ₹68 Cr | ₹67 Cr | ₹63 Cr | ₹61 Cr | ₹50 Cr | ₹44 Cr | ₹45 Cr | ₹29 Cr | ₹63 Cr | ₹68 Cr | ₹71 Cr | ₹26 Cr |
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|
| — | — | — |
| ₹23 Cr | ₹23 Cr | ₹2 Cr |
| ₹0 | ₹1 Cr | ₹23 Cr |
| ₹361 Cr | ₹249 Cr | ₹183 Cr |
| ₹361 Cr | ₹249 Cr | ₹183 Cr |
| ₹384 Cr | ₹273 Cr | ₹208 Cr |
| -₹9 Cr | -₹6 Cr | -₹2 Cr |
| ₹17 Cr | ₹17 Cr | ₹0 |
| ₹221 Cr | ₹11 Cr | ₹8 Cr |
| ₹230 Cr | ₹22 Cr | ₹6 Cr |
| — | — | — |
| ₹80 Cr | ₹70 Cr | ₹60 Cr |
| ₹13 Cr | ₹18 Cr | ₹0 |
| ₹36 Cr | ₹164 Cr | ₹70 Cr |
| ₹128 Cr | ₹252 Cr | ₹130 Cr |
| ₹742 Cr | ₹547 Cr | ₹344 Cr |
| ₹2 Cr | ₹60 L | ₹0 |
| — | — | — |
| ₹58 Cr | ₹40 Cr | ₹11 Cr |
| ₹23 Cr | ₹11 Cr | ₹6 Cr |
| ₹36 Cr | ₹29 Cr | ₹5 Cr |
| ₹0 | ₹70 L | ₹0 |
| ₹211 Cr | ₹2 Cr | ₹0 |
| ₹70 L | ₹1 Cr | ₹80 L |
| ₹248 Cr | ₹33 Cr | ₹8 Cr |
| — | — | — |
| ₹62 Cr | ₹41 Cr | ₹97 Cr |
| ₹30 Cr | ₹14 Cr | ₹32 Cr |
| ₹375 Cr | ₹327 Cr | ₹2 Cr |
| ₹3 Cr | ₹6 Cr | ₹205 Cr |
| ₹25 Cr | ₹126 Cr | ₹60 L |
| ₹494 Cr | ₹513 Cr | ₹335 Cr |
| ₹366 Cr | ₹261 Cr | ₹205 Cr |
| ₹742 Cr | ₹547 Cr | ₹344 Cr |
| ₹167 | ₹118 | ₹923 |
| ₹167 | ₹118 | ₹923 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Dec 2025 | Dec 2024 | Dec 2023 |
|---|---|---|
| ₹320 Cr | ₹247 Cr | ₹219 Cr |
| -₹4 Cr | ₹50 L | -₹2 Cr |
| -₹54 Cr | ₹316 Cr | -₹213 Cr |
| ₹262 Cr | ₹563 Cr | ₹4 Cr |
| ₹175 Cr | ₹439 Cr | -₹40 L |
| ₹8 Cr | ₹2 Cr | ₹0 |
| -₹135 Cr | -₹116 Cr | ₹2 Cr |
| ₹48 Cr | ₹325 Cr | ₹2 Cr |
| ₹327 Cr | ₹2 Cr | ₹0 |
| ₹375 Cr | ₹327 Cr | ₹2 Cr |
Fundamental Ratios
Consolidated
Standalone
No results found